Akebia Therapeutics And 20 Stocks Moving Premarket

Loading...
Loading...

Gainers

  • Quoin Pharmaceuticals, Ltd. QNRX rose 83.2% to $0.8250 in pre-market trading after dropping 10% on Thursday.
  • Fast Radius, Inc. FSRD rose 57.2% to $0.9900 in pre-market trading after jumping over 37% on Thursday. Fast Radius recently appointed Pat McCusker as President, Interim CFO and John Nanry as COO.
  • Akebia Therapeutics, Inc. AKBA rose 33.1% to $0.4701 in pre-market trading after the company executed an agreement to terminate its vadadustat collaboration and license agreements with Otsuka Pharmaceutical.
  • Shift Technologies, Inc. SFT rose 27.7% to $0.86 in pre-market trading after declining around 7% on Thursday.
  • ECMOHO Limited MOHO rose 27.5% to $0.2093 in pre-market trading after dropping over 4% on Thursday.
  • AcelRx Pharmaceuticals, Inc. ACRX rose 22.8% to $0.30 in pre-market trading.
  • OceanPal Inc. OP rose 15.5% to $0.55 in pre-market trading. OceanPal recently announced entry into agreement to acquire capesize dry bulk vessel.
  • Missfresh Limited MF shares rose 9.8% to $0.28 in pre-market trading after declining around 10% on Thursday.
  • Embark Technology, Inc. EMBK rose 8.9% to $0.55 in pre-market trading after dropping more than 8% on Thursday.
  • Scopus BioPharma Inc. SCPS shares rose 7% to $0.46 in pre-market trading after jumping 14% on Thursday.
  • Imperial Petroleum Inc. IMPP rose 6.1% to $0.4459 in pre-market trading after dipping over 10% on Thursday. Imperial Petroleum recently announced the receipt of Nasdaq notice.


Don’t forget to check out our premarket coverage here .

Losers

  • Kohl's Corporation KSS fell 17.2% to $29.56 in pre-market trading. CNBC, last week, reported that Franchise Group is considering lowering Kohl's bid closer to $50 a share from about $60.
  • Revelation Biosciences, Inc. REVB fell 14.4% to $0.95 in pre-market trading after jumping 77% on Thursday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for treatment of allergic rhinitis.
  • Borr Drilling Limited BORR fell 14.3% to $3.95 in pre-market trading after dropping 15% on Thursday.
  • Biophytis S.A. BPTS shares fell 11.5% to $1.00 in pre-market trading after the company announced the drawing of the second tranche of Ornane under the 2021 Atlas contract for €4 million.
  • Dermata Therapeutics, Inc. DRMA shares fell 9.8% to $0.5865 in pre-market trading after jumping around 20% on Thursday.
  • Endo International plc ENDP fell 9.4% to $0.4221 in pre-market trading. Endo International shares dropped over 10% on Thursday after the company said it has elected to not make a $38 million interest payment with respect to its outstanding 6.00% Senior Notes due 2028.
  • ShiftPixy, Inc. PIXY fell 8.9% to $0.2880 in pre-market trading after gaining around 7% on Thursday.
  • Ensysce Biosciences, Inc. ENSC fell 6.3% to $0.8137 in pre-market trading after jumping around 73% on Thursday.
  • Agile Therapeutics, Inc. AGRX fell 6.3% to $1.09 in pre-market trading. Agile Therapeutics recently filed for an offering of up to approximately 15.75 million shares.
  • Micron Technology, Inc. MU fell 3.1% to $53.60 in pre-market trading. Micron reported upbeat financial results for its third quarter, but issued weak guidance for its fourth quarter.
Loading...
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...